Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 12, Pages -Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.2022403118
Keywords
cancer; Ras proteins; native mass spectrometry; Ras-SOS
Categories
Funding
- National Cancer Institute (NCI)
- National Institute of General Medical Sciences (NIGMS) [R01GM121751]
- NIGMS [DP2GM123486]
- National Institute of Health (NIH) [P41GM128577]
- NIH Common Fund Transformative High-Resolution Cryo-Electron Microscopy Program [U24 GM129539]
- Simons Foundation [SF349247]
- New York State Assembly
Ask authors/readers for more resources
This study investigated the interaction of oncogenic Ras mutants with SOS using native ion mobility-mass spectrometry and structural analysis, revealing different molecular assemblies and the potent modulatory effects of certain mutants on SOS. The findings provide insights into potential therapeutic interventions for Ras-driven cancers.
Ras is regulated by a specific guanine nucleotide exchange factor Son of Sevenless (SOS), which facilitates the exchange of inactive, GDP-bound Ras with GTP. The catalytic activity of SOS is also allosterically modulated by an active Ras (Ras-GTP). However, it remains poorly understood how oncogenic Ras mutants interact with SOS and modulate its activity. Here, native ion mobility-mass spectrometry is employed to monitor the assembly of the catalytic domain of SOS (SOScat) with KRas and three cancer-associated mutants (G12C, G13D, and Q61H), leading to the discovery of different molecular assemblies and distinct conformers of SOScat engaging KRas. We also find KRas(G13D) exhibits high affinity for SOScat and is a potent allosteric modulator of its activity. A structure of the KRas(G13D).SOScat complex was determined using cryogenic electron microscopy providing insight into the enhanced affinity of the mutant protein. In addition, we find that KRas(G13D)-GTP can allosterically increase the nucleotide exchange rate of KRas at the active site more than twofold compared to KRas-GTP. Furthermore, small-molecule Ras.SOS disruptors fail to dissociate KRas(G13D).SOScat complexes, underscoring the need for more potent disruptors. Taken together, a better understanding of the interaction between oncogenic Ras mutants and SOS will provide avenues for improved therapeutic interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available